EATG » R&D

R&D

Hookipa and Gilead enter into a collaboration and license agreement to develop immunotherapies against HIV and hepatitis B

-- Hookipa and Gilead will jointly develop therapeutics against HIV and Hepatitis B infections -- Hookipa and Gilead will jointly research and Hookipa will manufacture arenavirus-based vectors for clinical development…

Analysis links US government global health R&D funding to jobs, economic benefits across states

As White House seeks big cuts in global health research, new state-by-state analysis shows US government investment brings jobs, health security to states while saving millions of lives worldwide The…

HIVACAR: EATG reports from the second general assembly of the consortium

On March 15-16 the European AIDS Treatment Group participated in the second general assembly meeting of the HIVACAR consortium in Digem (Belgium). The EATG in collaboration with the Complutense University…

Metrodora: Call for applications in the Multi-Stakeholders’ Meeting

Call for applications: Multi-Stakeholders’ Meeting Meaningful Engagement of Women in HIV Treatment Research Wednesday 16 May 2018, Park Inn Hotel, Brussels, Belgium   The Meeting: Within the framework of the…

Inovio and The Wistar Institute to advance vaccines against TB & malaria

Inovio and The Wistar Institute receive more than $4.6 million in R&D funding to advance vaccines against TB & malaria PLYMOUTH MEETING, Pa., Feb. 12, 2018 -- Inovio Pharmaceuticals, Inc.…

Otsuka to advance development of novel TB compound

Otsuka awarded grant to advance development of novel TB compound OPC-167832 with delamanid TOKYO, Japan & PRINCETON, NJ, USA I January 29, 2018 -- Otsuka Pharmaceutical Co., Ltd., and its…

EFGCP Conference Coming Up in February

The upcoming conference of the European Forum for Good Clinical Practice holds its next conference in Brussels in February 2018. The conference will pay special attention to the consequences of…

R&D for neglected diseases reliant on just two donors, G-FINDER report warns

LONDON, 14 December 2017 — Funding for research and development into neglected diseases has increased for the first time in recent years, driven by investments from the United States, a new…

WHO policy paper calls for increased investments in TB research to reach end TB targets

28 November 2017 | Geneva: The World Health Organization released a policy paper during the First WHO Global Ministerial Conference on Ending TB on 17 November, highlighting the persistent investment gaps…

Vital microbicides may soon be out of reach

Whether, when, and how microbicide development proceeds depends on the U.S government, and the federal Division of AIDS has suggested this development may no longer be a priority. It's wrong.…

1 2 3 6